Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Virology Journal
Published in: Virology Journal 1/2011

Open Access 01-12-2011 | Short report

Prevalence of porcine circovirus-like agent P1 in Jiangsu, China

Authors: Libin Wen, Kongwang He, Hanchun Yang, Zhengyu Yu, Aihua Mao, Shulin Zhong, Yanxiu Ni, Xuehan Zhang, Bin Li, Xiaomin Wang, Junming Zhou, Rongli Guo, Lixin Lv, Jieyuan Jiang

Published in: Virology Journal | Issue 1/2011

Login to get access

Abstract

Recently, we identified a novel porcine circovirus type 2-like agent P1 isolate from swine. The present study represents the first survey of P1 prevalence in swine herds from Jiangsu, China, by using PCR targeting the complete genome of P1. Prevalences of 50% and 19% were found among 6 herds and 248 animals, respectively. The results indicate a high prevalence of P1 in China pig populations.
Appendix
Available only for authorised users
Literature
1.
Tischer I, Gelderblom H, Vettermann W, Koch MA: A very small porcine virus with circular single-stranded DNA. Nature 1982, 295: 64-66. 10.1038/295064a0CrossRefPubMed
2.
Tischer I, Bode L, Peters D, Pociuli S, Germann B: Distribution of antibodies to porcine circovirus in swine populations of different breeding farms. Arch Virol 1995,140(4):737-743. 10.1007/BF01309961CrossRefPubMed
3.
Allan GM, McNeilly F, Kennedy S, Daft B, Clarke EG, Ellis JA, Haines DM, Meehan BM, Adair BM: Isolation of porcine circovirus-like viruses from pigs with a wasting disease in the USA and Europe. J Vet Diagn Invest 1998,10(1):3-10. 10.1177/104063879801000102CrossRefPubMed
4.
Ellis J, Hassard L, Clark E, Harding J, Allan G, Willson P, Strokappe J, Martin K, McNeilly F, Meehan B, Todd D, Haines D: Isolation of circovirus from lesions of pigs with postweaning multisystemic wasting syndrome. Can Vet J 1998, 39: 44-51.PubMedCentralPubMed
5.
Harding JCS, Clark EG: Recognizing and diagnosing postweaning multisystemic wasting syndrome (PMWS). J Swine Health Prod 1997, 5: 201-203.
6.
Rosell C, Segalés J, Plana-Duran J, Balasch M, Rodriguez-Arrioja GM, Kennedy S, Allan GM, McNeilly F, Latimer KS, Domingo M: Pathological, immunohistochemical, and in situ hybridization studies of natural cases of postweaning multisystemic wasting syndrome (PMWS) in pigs. J Comp Pathol 1999, 120: 59-78. 10.1053/jcpa.1998.0258CrossRefPubMed
7.
Wen L, He K, Yang H: Sequencing and analysis of complete genome of a porcine circovirus type 2-like agent P1. Sci Agric Sin 2010,43(2):411-416. (in Chinese with English abstract)
8.
Wen L, He K, Yang H, Ni Y, Zhang X, Guo R, Pan Q: Complete nucleotide sequence of a novel porcine circovirus-like agent and its infectivity in vitro. Sci China C Life Sci 2008,51(5):453-458. 10.1007/s11427-008-0053-5CrossRefPubMed
9.
Harding JC: Post-weaning multisystemic wasting syndrome: preliminary epidemiology and clinical findings. Proceedings of the Western Canadian Association on Swine Practice 1996 21.
10.
Segalés J, Allan GM, Domingo M: Porcine circovirus diseases. Anim Health Res Rev 2005, 6: 119-142. 10.1079/AHR2005106CrossRefPubMed
11.
Allan GM, Kennedy S, McNeilly F, Foster JC, Ellis JA, Krakowka SJ, Meehan BM, Adair BM: Experimental reproduction of severe wasting disease by co-infection of pigs with porcine circovirus and porcine parvovirus. J Comp Pathol 1999, 121: 1-11. 10.1053/jcpa.1998.0295CrossRefPubMed
12.
Krakowka S, Ellis JA, Meehan B, Kennedy S, McNeilly F, Allan G: Viral wasting syndrome of swine: experimental reproduction of postweaning multisystemic wasting syndrome in gnotobiotic swine by coinfection with porcine circovirus 2 and porcine parvovirus. Vet Pathol 2000, 37: 254-263. 10.1354/vp.37-3-254CrossRefPubMed
13.
Allan GM, McNeilly F, Ellis J, Krakowka S, Meehan B, McNair I, Walker I, Kennedy S: Experimental infection of colostrum deprived piglets with porcine circovirus 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) potentiates PCV2 replication. Arch Virol 2000, 145: 2421-2429. 10.1007/s007050070031CrossRefPubMed
14.
Harms PA, Sorden SD, Halbur PG, Bolin SR, Lager KM, Morozov I, Paul PS: Experimental reproduction of severe disease in CD/CD pigs concurrently infected with type 2 porcine circovirus and porcine reproductive and respiratory syndrome virus. Vet Pathol 2001, 38: 528-539. 10.1354/vp.38-5-528CrossRefPubMed
15.
Ellis J, Allan G, Krakowka S: Effect of coinfection with genogroup 1 porcine torque teno virus on porcine circovirus type 2-associated postweaning multisystemic wasting syndrome in gnotobiotic pigs. Am J Vet Res 2008,69(12):1608-1614. 10.2460/ajvr.69.12.1608CrossRefPubMed
16.
Opriessnig T, Thacker EL, Yu S, Fenaux M, Meng XJ, Halbur PG: Experimental reproduction of postweaning multisystemic wasting syndrome in pigs by dual infection with Mycoplasma hyopneumoniae and porcine circovirus type 2. Vet Pathol 2004,41(6):624-640. 10.1354/vp.41-6-624CrossRefPubMed
17.
Pogranichniy RM, Yoon KJ, Harms PA, Sorden SD, Daniels M: Case-control study on the association of porcine circovirus type 2 and other swine viral pathogens with postweaning multisystemic wasting syndrome. J Vet Diagn Invest 2002,14(6):449-456. 10.1177/104063870201400601CrossRefPubMed
18.
Lohse L, Botner A, Hansen AS, Frederiksen T, Dupont K, Christensen CS, Baekbo P, Nielsen J: Examination for a viral co-factor in postweaning multisystemic wasting syndrome (PMWS). Vet Microbiol 2008, 129: 97-107. 10.1016/j.vetmic.2007.11.018CrossRefPubMed
Metadata
Title
Prevalence of porcine circovirus-like agent P1 in Jiangsu, China
Authors
Libin Wen
Kongwang He
Hanchun Yang
Zhengyu Yu
Aihua Mao
Shulin Zhong
Yanxiu Ni
Xuehan Zhang
Bin Li
Xiaomin Wang
Junming Zhou
Rongli Guo
Lixin Lv
Jieyuan Jiang
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2011
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-8-543

Other articles of this Issue 1/2011

Virology Journal 1/2011 Go to the issue

Research

Intramuscular immunization of mice with live influenza virus is more immunogenic and offers greater protection than immunization with inactivated virus

Short report

Genetic characterization of porcine circovirus type 2 in piglets from PMWS-affected and -negative farms in Thailand

Short report

Latent HIV in primary T lymphocytes is unresponsive to histone deacetylase inhibitors

Research

Molecular epidemiology of hcv among health care workers of khyber pakhtunkhwa

Research

Identification of genotype 4 Hepatitis E virus binding proteins on swine liver cells

Research

Characterization of Hepatitis C Virus genotype 3a Hypervariable region 1 in patients achieved rapid virological response to alpha interferon and Ribavirin Combination therapy
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits